Continuing

Education

Continuing

Education

CATEGORY

BESST Study: Benazepril Spironolactone STudy (Cardiology)

RACE-Approved 1 Hour CE Course

The pivotal trial for Cardalis will be described in detail, with methods and results. Clinical applications for this drug will also be discussed. The attendee will learn how the drug was evaluated and of its efficacy and safety.

DELAY Study: DELay of Appearance of sYmptoms of canine degenerative mitral valve disease treated with spironolactone and benazepril (Cardiology)

RACE-Approved 0.5 Hour CE Course

Dr. Borgarelli will provide a review of the DELAY study. He will touch on the prognostic significance of cardiac remodeling in dogs with MMVD and how cardiac biomarkers can be used in clinical trials.

Rational Dose Selection for ACE Inhibitors in Canine Heart Disease (Cardiology)

RACE-Approved 0.5 Hour CE Course

Although ACE inhibitors are among the most commonly prescribed medications in veterinary cardiology, no consensus exists on the ideal dose of ACEi for treatment of heart disease, systemic hypertension, or proteinuria. The purpose of this presentation is to review the existing evidence and future research directions that can assist clinicians in choosing the optimal dose of ACEi for their patients.

Importance of RAAS Suppression in Canine Heart Failure (Cardiology)

RACE-Approved 1 Hour CE Course

Speakers will review the timing and consequences of chronic RAAS activation in cardiac disease in dogs. Based on currently published studies and ACVIM Consensus Statements, a comprehensive plan for stage-by-stage medical management of myxomatous mitral valve disease will be presented.

Staff Rewards

START SAVING

Connect with Ceva

SIGN UP

Customer Service

CONTACT US

Ceva Animal Health offers many products designed to help keep pets healthier inside and out. Learn more about our company by visiting www.ceva.us.

© 2017 Ceva Animal Health, LLC
Terms of Use | Cookies Policy | Privacy Policy